Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
In response to the Monacolin K discussion previously on this BB
To support food brands, retailers and consumers in making the switch from Monacolin K to another alternative solution, CholBiome®CH. contains two active ingredients in a bi-layer tablet – the company’s patented probiotic backed by multiple independent studies, Lactobacillus plantarum LPLDL®, and Plant Sterols / Stanols (PSS). These combine synergistically to support the reduction of both internal and dietary cholesterol levels via its dual action cholesterol reducing formula.
https://optibiotix.com/probiotix-health-launches-cholbiomech-at-vitafoods-europe/?utm_source=twitter&utm_medium=social&utm_campaign&utm_content=ap_tr3ap9n9ih
Steen commented
This new allergen and GMO-free innovation delivers a dual mechanism of action, where the award-winning ingredient LPLDL acts on the internal cholesterol to produce enzymes that break down bile salts. This encourages the liver to remove cholesterol from the blood to replenish required levels and maintain the body’s bile salt pool. Through the secondary action, PSS reduces dietary cholesterol absorption and promotes excretion.
Due to the inclusion of PSS, CholBiome®CH can claim to contribute to the maintenance of normal blood cholesterol levels, as backed by EFSA4.
“High levels of cholesterol have been commonly tackled by approaches that come with multiple undesirable side effects,” continued Andersen. “Yet LPLDL offers a scientific, side-effect free alternative to improve cardiovascular health. The naturally occurring probiotic strain has demonstrated its efficacy in several human studies showing that it can effectively lower total cholesterol and ‘bad’ LDL cholesterol, while increasing ‘good’ HDL cholesterol. As a leader in the microbiome modulation area, consumers and those in the industry can rest assured that we continuously expand the clinical studies supporting the efficacy of CholBiome and LPLDL.”
mol
Are these POS shares ever going to be worth anything like they cost vs OPTIs downfall.
I'm just holding on the possibility of them getting onto AIM but we were due Q1 news at some point as well.
Yes, have you?
Has this stock got a Telegram Group ?
Cheap and why I took some weeks back GLA
This is by virtue of their investment in Opti, luckily they take their valuation from before the lock in ended :-D
At least one Institution sees the value potential here
"ProBiotix Health Plc – A company established by OptiBiotix
Health Plc, a B share pool existing investment, to develop
probiotics to tackle cardiovascular disease and other lifestyle
conditions which are affecting growing numbers of people
across the world.
£777k"
https://senecavct.co.uk/wp-content/uploads/2023/04/Seneca-VCT-Annual-Report-April-2023-Signed.pdf
Clolerice designed around lpldl due to the change in legislation regarding red yeast and monacolin k
In case anybody's been looking, aquis has changed their weblink to the PBX trades:
https://www.aquis.eu/companies/PBX/trades
End of Q1 monster sales update as promised has not materialized.. OPTI/SBTX/PBX have been absolute dogs. Are they now so bombed out that they are great value? I won't be selling but certainly won't be buying either. What a mess.
In addition to Wellbiome now LPLDL as well
https://www.denkingredients.de/lpldl-ein-patentiertes-probiotikum-fur-die-herzgesundheit/
Hopefully the above is translated version
mol
First noted tensred back on Opti bb on 14 Dec 2021 - anyway bit more up to date info below and the relative recent release of tensred plus
https://www.nutritioninsight.com/technical-papers/tensred-plus%C2%AE-by-biofarma-group-a-clinically-validated-nutraceutical-support-to-manage-pre-hypertension.html
from above to below
https://www.biofarmagroup.it/en/innovative-nutraceutical-solution-pre-hypertension-biofarma-group/
extract
The observation was performed on a sample of 40 patients over 18 and of both sexes with pre-hypertension. They were asked to take the nutraceutical composition for several months, once a day at breakfast time. The main results obtained from the clinical study are as follows: a significant reduction in mean systolic blood pressure (SBP -4.1 mmHg, p= 0.041) and mean diastolic blood pressure (DBP -3.0 mmHg, p= 0.044) was observed, the focus of the investigation. Although these values can suggest a result that is not particularly significant if we consider that the object of the observation is a nutraceutical product used on substantially still healthy subjects who are only in a situation at risk of developing the disease. In addition, a significant reduction in total cholesterol (CT -13.5 mg/dl) and low-density lipoproteins, more commonly known as “bad cholesterol” (LDL-C -11.4 mg/dl), was also observed.
In conclusion, you can say that the clinical trial demonstrated the efficacy of the identified nutraceutical compound to support patients with pre-hypertension, reducing blood pressure values and counteracting the progression of the state toward one of the hypertension arteries a. This is a significant result, especially if we consider that this is one of the few, if not, the only pilot study which evaluated subjects in a state of pre-hypertension, consistent with the increasing importance attributed by the medical community to timely intervention in this preliminary phase of the disease.
From these results, Tensred plus® was born, whose effectiveness is therefore given by the synergy of four mechanisms of action: L-arginine, an amino acid considered vasodilator; Vitamin B1 (thiamine) that contributes to the normal functioning of the heart (EFSA authorized claim); L. Plantarum LPLDL®, which improves blood pressure through mechanisms that include improving total cholesterol and low-density lipoprotein cholesterol levels, reducing blood glucose level and insulin resistance; in fine Coenzyme Q10, antioxidant able to act on both systolic and diastolic pressure and whose deficiency is therefore associated with cardiovascular diseases.
mol
slipped again!
Mar to Apr to now May 23
https://optibiotix.online/collections/cholbiome-range
with the earliest review for either x3 or BP on online shop is now over a year ago
mol
No not us unfortunately
https://www.dailymail.co.uk/health/article-11821779/New-cholesterol-lowering-pill-cuts-risk-heart-attack-stroke.html
mol
oops last word Anpartsselskab is just
Limited Liability Company.
mol
seemingly a new company registered 23 Jan 2023 in Denmark with Steen as sole Director and owned by us
https://ownr-dk.translate.goog/companies/public-profile/43827774?_x_tr_sl=da&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc
with its purpose
The purpose of the company
The company's purpose is to offer consultancy services linked to digital learning solutions and to sell digital learning platforms.
not sure what that has to do with us!
another link
https://vismarating.dk/firma/43827774-probiotix-health-denmark-aps?_x_tr_sl=da&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc
translation of blurb at outset
The company Probiotix Health Denmark ApS is in the industry "Consulting support regarding information technology" and has an address in Søborg. They were established on 23 January 2023 and are of the company type Anpartsselskab.
mol
From listing. PBX will be on AIM by Sept/Oct imv. Should be worth multiples of current Mcap by then
SOH as positive as ever. Thinks Steen can really drive sales in PBX. And restates his view that PBX will be a takeover target in a couple of years. Also says, movement from Aquis to AIM is cheaper after 18 months. Is that from now or from 1st listing? Assume former?
We shall see.
btw seed health have moved on substantially re shipping from their early days
https://seed.com/entire-world
still our biggest customer
mol
awaiting 3 and 4 on list re ds-01
https://clinicaltrials.gov/ct2/results?cond=&term=&type=&rslt=&age_v=&gndr=&intr=&titles=&outc=&spons=seed+health&lead=&id=&cntry=&state=&city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=
mol
Check out Ara Katz comments from around 38 mins into this podcast.. sounds like the DS01 results are in and they are good (inferring from her comments!). Strong results will open up the Pharmaceutical route, giving a shot in the arm for sales of DS01, and by association LPDLDL. Not to mention the credibility boost!
https://www.modernretail.co/marketing/we-write-nature-papers-and-we-write-instagram-posts-seed-healths-ara-katz-on-evangelizing-the-microbiome/
From Sacco last year
https://www.saccosystem.com/public/pdf/Page/LPldl_jul22.pdf
and the undernoted, from Gabriela Sales, a month ago promoting the same info
CSL Cultures supporting life | Technical Sales
Yes, yes, yes... we all love yogurt! Protein, fat, carbs, live and active cultures... all that we need! What if we can do a little more?
Cholesterol is a significant problem for our cardiovascular health. Some people might see their cholesterol spike even with exercise and balanced nutrition. And that's where probiotics come to aid!
Want to learn more about this huge breakthrough? I will be happy to assist!
https://cslusa.com/#about-us
mol